Bellevue Asset Management
Bellevue Asset Management AG is a Swiss specialty asset manager offering actively managed healthcare, small & mid-cap, and multi-asset funds to institutional, qualified, and retail investors across Europe and Asia Pacific.
- Company typePrivate
- Founded1993
- HeadquartersKusnacht, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Bellevue Asset Management does
Bellevue Asset Management AG is a Swiss specialty asset manager and wholly owned subsidiary of publicly listed Bellevue Group AG (SIX Swiss Exchange), founded in 1993 and headquartered in Zurich with offices in London, Frankfurt, Singapore, and Dublin. The firm operates as an active, fundamental bottom-up equity manager concentrated in three pillars: healthcare investments (biotech, medtech, digital health, AI health, obesity solutions, and longevity themes via BB Biotech AG, the Bellevue Healthcare UCITS ETF, and dedicated thematic funds), small & mid-cap entrepreneurial investments (Swiss and European listed small-caps plus private equity strategies), and multi-asset/bond strategies (Bellevue Global Macro and Bellevue Global Income). Assets under management stood at CHF 4.8 billion at H1 2025, down from a 2021 peak of CHF 14.4 billion.
Bellevue Asset Management firmographics
Firmographics- Name
- Bellevue Asset Management
- Legal name
- Bellevue Asset Management AG
- Website
- https://bellevue.ch
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bellevue Asset Management AG is a Swiss specialty asset manager offering actively managed healthcare, small & mid-cap, and multi-asset funds to institutional, qualified, and retail investors across Europe and Asia Pacific.
- Ownership category
- akta.pro rank
Bellevue Asset Management industry classification
Industry- Product category
- Healthcare-focused asset management
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Healthcare & Life Sciences Growth Equity (FSANACAB)
Keywords
Where Bellevue Asset Management is headquartered
LocationHeadquarters
- HQ city
- Kusnacht
- HQ country
- Switzerland
- HQ region
- Europe
Offices5 records
Markets served
Bellevue Asset Management business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
Revenue model
- Fund Management Fees: Recurring management fees charged on assets under management across Bellevue Funds (Lux) SICAV, Swiss investment funds, and third-party mandates. Fee income is directly tied to the AuM base, which stood at CHF 4.8 billion in H1 2025.
- Performance Fees: Success fees charged when investment funds meet or exceed defined performance targets relative to their benchmarks, as described in fund documentation (BVI method).
- ETF Operations: Revenue from actively managed Bellevue Healthcare UCITS ETF listed on SIX Swiss Exchange and Deutsche Börse Xetra, providing healthcare exposure through a UCITS-compliant wrapper.
- Operating Activities for BB Biotech AG: Bellevue Asset Management is responsible for the operating activities, administration, and marketing of BB Biotech AG, a separately listed investment company focused on biotechnology.
Go-to-market motion1 record
Distribution channels6 records
Marketing channels6 records
Bellevue Asset Management product offering
Product offeringCore offering
Bellevue Asset Management AG is a Swiss specialty asset manager that operates investment funds and mandates concentrated on healthcare (biotech, medtech, digital health, AI health, obesity solutions, and longevity themes), small and mid-cap entrepreneur companies, and multi-asset/bond strategies. The firm manages BB Biotech AG, runs Luxembourg UCITS SICAV and Swiss-domiciled funds, and launched its first actively managed ETF (Bellevue Healthcare UCITS ETF) in September 2025.
Product overview
Bellevue Asset Management operates as a specialty investment manager offering a diversified portfolio of investment products. The core offering centers on Healthcare Investments including biotech (BB Biotech AG, Bellevue Biotech CH), medtech (Bellevue Medtech & Services), and thematic healthcare funds (Bellevue AI Health, Bellevue Digital Health, Bellevue Obesity Solutions, Bellevue Healthcare ETF). The Healthcare Global category includes diversified and sustainable healthcare strategies, while Regional Healthcare covers Asia Pacific and Emerging Markets. Beyond healthcare, Bellevue provides Small & Mid Sized Entrepreneur Investments including listed Swiss and European small caps and private equity (Bellevue Entrepreneur Private), plus Multi Asset & Bonds strategies (Bellevue Global Macro, Bellevue Global Income). The product suite operates across multiple legal structures including Swiss funds, Luxembourg SICAV, and UCITS ETFs, distributed through institutional and retail channels in Switzerland, Germany, Austria, Spain, and Luxembourg.
Differentiator
Problem solved
Functional benefit
Brands
- Bellevue Healthcare ETF: Actively managed UCITS ETF focused on global healthcare stocks, listed on SIX Swiss Exchange and Deutsche Börse Xetra.
- Bellevue Medtech & Services
- Bellevue Digital Health
- Bellevue AI Health
- Bellevue Obesity Solutions
- Bellevue Diversified Healthcare
- Bellevue Sustainable Healthcare
- Bellevue Healthcare Strategy
- Bellevue Asia Pacific Healthcare
- Bellevue Emerging Markets Healthcare
- Bellevue Biotech (CH)
- Bellevue Entrepreneur Europe Small
- Bellevue Entrepreneur Swiss Small & Mid
- Bellevue Entrepreneur Switzerland (CH)
- Bellevue Entrepreneur Private
- Bellevue Global Macro
- Bellevue Global Income
- BB Biotech AG
Products and services
- BB Biotech AG Investment company listed on SIX Swiss Exchange and German Prime Standard, focused on investing in biotechnology companies globally. Bellevue Asset Management is responsible for its operating activities, administration, and marketing.
- Bellevue Biotech (CH) Swiss-domiciled fund focusing on biotechnology company investments for professional and qualified investors.
- Bellevue Medtech & Services Fund investing in medical technology and healthcare services companies, marking over 15 years of active management.
- Bellevue AI Health Thematic fund focusing on AI-driven healthcare innovation and technologies.
- Bellevue Digital Health Thematic fund targeting digital health monitoring and healthcare technology companies.
- Bellevue Obesity Solutions Thematic fund focusing on companies addressing obesity treatment and related healthcare solutions.
- Bellevue Diversified Healthcare Diversified healthcare fund providing broad exposure to the global healthcare sector.
- Bellevue Healthcare UCITS ETF Actively managed UCITS ETF investing in top healthcare stocks, listed on SIX Swiss Exchange and Deutsche Börse Xetra. Benchmark: MSCI World Healthcare Index.
- Bellevue Healthcare Strategy Core healthcare equity strategy providing global healthcare exposure through active management.
- Bellevue Sustainable Healthcare Sustainable healthcare fund incorporating ESG criteria into healthcare investments.
- Bellevue Asia Pacific Healthcare Regional healthcare fund focusing on Asia Pacific healthcare companies.
- Bellevue Emerging Markets Healthcare Regional healthcare fund focusing on emerging markets healthcare opportunities.
- Bellevue Entrepreneur Europe Small Fund investing in small and mid-sized European entrepreneurial companies.
- Bellevue Entrepreneur Swiss Small & Mid Fund investing in Swiss small and mid-sized companies.
- Bellevue Entrepreneur Switzerland (CH) Swiss-domiciled fund focusing on Swiss entrepreneurial companies.
- Bellevue Entrepreneur Private Private equity fund focused on entrepreneurial companies, including private equity secondaries and direct private market investments for qualified investors.
- Bellevue Global Macro Multi-asset fund using global macro investment strategies.
- Bellevue Global Income Bond fund focused on global income strategies.
Quantifiable outcome
- Healthcare sector re-rating potential identified based on 13% valuation discount to global stocks, with USD 180 billion in biopharma M&A capacity.
- +3 more outcomes
Companies that use Bellevue Asset Management
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Bellevue Asset Management technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Bellevue Asset Management partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered minor and core.
- Columbia ThreadneedleminorColumbia Threadneedle has been proposed by Bellevue Healthcare as the new fund manager for the Bellevue Healthcare Trust, as part of streamlining UK activities and operational restructuring.
- Waystone ETF ICAVcoreWaystone ETF ICAV is the open-ended Irish collective asset-management vehicle (umbrella fund) that hosts the Bellevue Healthcare UCITS ETF sub-fund. Authorised by the Central Bank of Ireland. The ETF is registered for public distribution in Switzerland and Germany.
- Waystone Fund Services (Switzerland) SAcoreOfficial representative in Switzerland for Bellevue Funds (Lux) SICAV, located at Avenue Villamont 17, CH-1005 Lausanne. Responsible for fund distribution oversight in the Swiss market.
- DZ PRIVATBANK (Schweiz) AGcorePaying agent in Switzerland for Bellevue Funds (Lux) SICAV, located at Münsterhof 12, CH-8022 Zürich. Handles subscription and redemption processing for Swiss investors.
- CACEIScoreCACEIS Investor Services Bank S.A. is responsible for fund administration, custodian services, and order processing for Luxembourg-based Bellevue investment funds. Also serves as custodian for Bellevue Entrepreneur Switzerland.
- Swisscanto Fondsleitung AGcoreFund management company for Bellevue Funds under Swiss law, located at Bahnhofstrasse 9, 8001 Zürich. Responsible for fund administration and compliance for Swiss-regulated Bellevue investment funds.
- PMG Investment Solutions AGcoreFund management company for Bellevue Entrepreneur Switzerland fund under Swiss law, located at Dammstrasse 23, 6300 Zug. Co-manages Swiss-regulated small and mid-cap entrepreneurial investment products.
- Zürcher KantonalbankcoreCustodian bank for Bellevue Funds under Swiss law, providing secure custody services for fund assets. Located in Zurich.
- Zeidler Legal Process Outsourcing Ltd.minorInformation and paying agent for Germany and Austria, located at 19-22 Lower Baggot Street, Dublin 2, Ireland. Facilitates fund distribution and investor services for German and Austrian markets.
- VSG Datenschutzpartner UGminorEU data protection representative appointed by Bellevue Group AG to serve as point of contact for supervisory authorities and data subjects on all EU data protection matters, located at Am Kaiserkai 69, D-20457 Hamburg.
- Prico GmbHminorExternal data protection officer appointed for Bellevue Asset Management (Deutschland) GmbH, contacted via [email protected] at Unterer Markt 1, 49477 Ibbenbüren, Germany.
Scale indicators13 records
Recent moves8 records
Expansion highlights5 records
Bellevue Asset Management competitors and assessment
Company assessmentDirect peers
- Polar Capital Holdings: UK-listed specialist asset manager with a strong healthcare and biotechnology fund franchise (Polar Capital Global Healthcare, Polar Capital Biotechnology). Direct competitor in the specialist healthcare equity space with similar size and active fundamental approach.
- GAM Investments: Swiss asset manager with GAM Star Healthcare and similar specialty fund offerings. Comparable size and Swiss domicile, undergoing strategic restructuring - useful comparable for specialty asset manager economics.
- HBM Partners: Swiss-based healthcare-focused investment firm specializing in private and public healthcare investments. Highly comparable specialist healthcare investment model with similar Swiss domicile and concentrated healthcare mandate.
- Swisscanto Asset Management: Swiss asset management arm of Zürcher Kantonalbank, already a distribution partner of Bellevue. Comparable Swiss fund manager with similar regulatory standing and overlapping institutional client base in Swiss market.
- Robeco: Dutch asset manager with healthcare-focused strategies (including RobecoSAM Sustainable Healthy Living). Direct competitor in healthcare-specialist equity space with comparable active fundamental approach.
Broad incumbents
- Pictet Asset Management: Swiss private bank-affiliated asset manager with Pictet Health and Pictet Quest for Health strategies. Larger Swiss competitor with healthcare offerings but broader multi-asset, multi-region franchise compared to Bellevue's focused specialist positioning.
- BlackRock: World's largest asset manager with iShares Healthcare Innovation ETF and active healthcare strategies. Dominant incumbent with scale advantages in ETF and institutional channels that Bellevue's new UCITS ETF directly competes against.
- Vontobel Asset Management: Swiss-listed asset manager with healthcare and multi-asset capabilities. Larger incumbent Swiss peer with broader product range but overlapping mid-cap and thematic healthcare exposures.
- T. Rowe Price: Global asset manager with T. Rowe Price Health Sciences and Global Biotechnology Funds. Established broad incumbent with deep healthcare research capabilities, larger scale, and global distribution - competitive threat for institutional mandates.
- Janus Henderson Investors: Global asset manager with dedicated healthcare funds (Janus Henderson Global Healthcare). Larger incumbent offering healthcare exposure but as part of broader multi-asset, multi-region platform rather than specialist focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Bellevue Asset Management social profiles
Digital presenceBellevue Asset Management compliance and trust
Trust signalCompliance9 records
Bellevue Asset Management financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bellevue Asset Management leadership team
Management profileNumber of profiles
Profiles1 record
Bellevue Asset Management subsidiaries and ownership
Company hierarchySubsidiaries5 records
Bellevue Asset Management funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bellevue Asset Management M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bellevue Asset Management
What does Bellevue Asset Management do?
Bellevue Asset Management AG is a Swiss specialty asset manager that operates investment funds and mandates concentrated on healthcare (biotech, medtech, digital health, AI health, obesity solutions, and longevity themes), small and mid-cap entrepreneur companies, and multi-asset/bond strategies. The firm manages BB Biotech AG, runs Luxembourg UCITS SICAV and Swiss-domiciled funds, and launched its first actively managed ETF (Bellevue Healthcare UCITS ETF) in September 2025.
Is Bellevue Asset Management a public or private company?
Bellevue Asset Management is a private company. It is classified as corporate owned and is currently operating.
When was Bellevue Asset Management founded?
Bellevue Asset Management was founded in 1993. It employs 11 to 50 people.
Where is Bellevue Asset Management based?
Bellevue Asset Management is headquartered in Kusnacht, Switzerland, in the Europe region.
How does Bellevue Asset Management make money?
Four revenue lines are on record. Fund Management Fees are the primary driver. The others are performance Fees, ETF Operations and operating Activities for BB Biotech AG.
Who are Bellevue Asset Management's main competitors?
Direct peers on record are Polar Capital Holdings, GAM Investments, HBM Partners, Swisscanto Asset Management and Robeco. Broad incumbents are Pictet Asset Management, BlackRock, Vontobel Asset Management, T. Rowe Price and Janus Henderson Investors.
Does Bellevue Asset Management have an API?
No public API is recorded for Bellevue Asset Management.
What industry is Bellevue Asset Management in?
Bellevue Asset Management's product category is Healthcare-focused asset management. Its primary akta.pro industry code is FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 523940 and its SIC code is 6282.